SHIP1 MODULATORS AND METHODS RELATED THERETO

Compounds of formula (I): [Formula should be inserted here]; where [Formula should be inserted here], n, R1, R4a, R4b, R5, R7 and R8 are defined herein, or pharmaceutically acceptable salts thereof, are described herein. The disclosed compounds have activity as SHIP1 modulators, and thus may be used...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KHLEBNIKOV, VLADIMIR, SHAN, RUDONG, PETTIGREW, JEREMY D, MACKENZIE, LLOYD F, BOGUCKI, DAVID, RAYMOND, JEFFERY R, MACRURY, THOMAS B, HARWING, CURTIS
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KHLEBNIKOV, VLADIMIR
SHAN, RUDONG
PETTIGREW, JEREMY D
MACKENZIE, LLOYD F
BOGUCKI, DAVID
RAYMOND, JEFFERY R
MACRURY, THOMAS B
HARWING, CURTIS
description Compounds of formula (I): [Formula should be inserted here]; where [Formula should be inserted here], n, R1, R4a, R4b, R5, R7 and R8 are defined herein, or pharmaceutically acceptable salts thereof, are described herein. The disclosed compounds have activity as SHIP1 modulators, and thus may be used to treat any of a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of formula (I) in combination with a pharmaceutically acceptable carrier or diluent are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof. Se describen compuestos de la fórmula (I): (Ver Fórmula) en donde: n, R1, R4a, R4b, R5, R7 y R8 son como se define en la presente, o sales farmacéuticamente aceptables de los mismos; los compuestos descritos tienen actividad como moduladores de SHIP1 y por lo tanto se pueden usar para tratar cualquiera de una variedad de enfermedades, trastornos o afecciones en las que la modulación de SHIP1 sería beneficiosa; también se describen composiciones que comprenden un compuesto de fórmula (I) en combinación con un vehículo o diluente farmacéuticamente aceptable, y métodos de modulación de SHIP1 mediante la administración de tales compuestos a un animal en necesidad de lo mismo.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2015008873A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2015008873A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2015008873A3</originalsourceid><addsrcrecordid>eNrjZNAJ9vAMMFTw9XcJ9XEM8Q8KVnD0c1HwdQ3x8HcJVghyBQq6uiiEeLgGuYb48zCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeN8IIwNDUwMDCwtzY0djohQBAOCAJbM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SHIP1 MODULATORS AND METHODS RELATED THERETO</title><source>esp@cenet</source><creator>KHLEBNIKOV, VLADIMIR ; SHAN, RUDONG ; PETTIGREW, JEREMY D ; MACKENZIE, LLOYD F ; BOGUCKI, DAVID ; RAYMOND, JEFFERY R ; MACRURY, THOMAS B ; HARWING, CURTIS</creator><creatorcontrib>KHLEBNIKOV, VLADIMIR ; SHAN, RUDONG ; PETTIGREW, JEREMY D ; MACKENZIE, LLOYD F ; BOGUCKI, DAVID ; RAYMOND, JEFFERY R ; MACRURY, THOMAS B ; HARWING, CURTIS</creatorcontrib><description>Compounds of formula (I): [Formula should be inserted here]; where [Formula should be inserted here], n, R1, R4a, R4b, R5, R7 and R8 are defined herein, or pharmaceutically acceptable salts thereof, are described herein. The disclosed compounds have activity as SHIP1 modulators, and thus may be used to treat any of a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of formula (I) in combination with a pharmaceutically acceptable carrier or diluent are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof. Se describen compuestos de la fórmula (I): (Ver Fórmula) en donde: n, R1, R4a, R4b, R5, R7 y R8 son como se define en la presente, o sales farmacéuticamente aceptables de los mismos; los compuestos descritos tienen actividad como moduladores de SHIP1 y por lo tanto se pueden usar para tratar cualquiera de una variedad de enfermedades, trastornos o afecciones en las que la modulación de SHIP1 sería beneficiosa; también se describen composiciones que comprenden un compuesto de fórmula (I) en combinación con un vehículo o diluente farmacéuticamente aceptable, y métodos de modulación de SHIP1 mediante la administración de tales compuestos a un animal en necesidad de lo mismo.</description><language>eng ; spa</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160531&amp;DB=EPODOC&amp;CC=MX&amp;NR=2015008873A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160531&amp;DB=EPODOC&amp;CC=MX&amp;NR=2015008873A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KHLEBNIKOV, VLADIMIR</creatorcontrib><creatorcontrib>SHAN, RUDONG</creatorcontrib><creatorcontrib>PETTIGREW, JEREMY D</creatorcontrib><creatorcontrib>MACKENZIE, LLOYD F</creatorcontrib><creatorcontrib>BOGUCKI, DAVID</creatorcontrib><creatorcontrib>RAYMOND, JEFFERY R</creatorcontrib><creatorcontrib>MACRURY, THOMAS B</creatorcontrib><creatorcontrib>HARWING, CURTIS</creatorcontrib><title>SHIP1 MODULATORS AND METHODS RELATED THERETO</title><description>Compounds of formula (I): [Formula should be inserted here]; where [Formula should be inserted here], n, R1, R4a, R4b, R5, R7 and R8 are defined herein, or pharmaceutically acceptable salts thereof, are described herein. The disclosed compounds have activity as SHIP1 modulators, and thus may be used to treat any of a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of formula (I) in combination with a pharmaceutically acceptable carrier or diluent are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof. Se describen compuestos de la fórmula (I): (Ver Fórmula) en donde: n, R1, R4a, R4b, R5, R7 y R8 son como se define en la presente, o sales farmacéuticamente aceptables de los mismos; los compuestos descritos tienen actividad como moduladores de SHIP1 y por lo tanto se pueden usar para tratar cualquiera de una variedad de enfermedades, trastornos o afecciones en las que la modulación de SHIP1 sería beneficiosa; también se describen composiciones que comprenden un compuesto de fórmula (I) en combinación con un vehículo o diluente farmacéuticamente aceptable, y métodos de modulación de SHIP1 mediante la administración de tales compuestos a un animal en necesidad de lo mismo.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAJ9vAMMFTw9XcJ9XEM8Q8KVnD0c1HwdQ3x8HcJVghyBQq6uiiEeLgGuYb48zCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeN8IIwNDUwMDCwtzY0djohQBAOCAJbM</recordid><startdate>20160531</startdate><enddate>20160531</enddate><creator>KHLEBNIKOV, VLADIMIR</creator><creator>SHAN, RUDONG</creator><creator>PETTIGREW, JEREMY D</creator><creator>MACKENZIE, LLOYD F</creator><creator>BOGUCKI, DAVID</creator><creator>RAYMOND, JEFFERY R</creator><creator>MACRURY, THOMAS B</creator><creator>HARWING, CURTIS</creator><scope>EVB</scope></search><sort><creationdate>20160531</creationdate><title>SHIP1 MODULATORS AND METHODS RELATED THERETO</title><author>KHLEBNIKOV, VLADIMIR ; SHAN, RUDONG ; PETTIGREW, JEREMY D ; MACKENZIE, LLOYD F ; BOGUCKI, DAVID ; RAYMOND, JEFFERY R ; MACRURY, THOMAS B ; HARWING, CURTIS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2015008873A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2016</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KHLEBNIKOV, VLADIMIR</creatorcontrib><creatorcontrib>SHAN, RUDONG</creatorcontrib><creatorcontrib>PETTIGREW, JEREMY D</creatorcontrib><creatorcontrib>MACKENZIE, LLOYD F</creatorcontrib><creatorcontrib>BOGUCKI, DAVID</creatorcontrib><creatorcontrib>RAYMOND, JEFFERY R</creatorcontrib><creatorcontrib>MACRURY, THOMAS B</creatorcontrib><creatorcontrib>HARWING, CURTIS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KHLEBNIKOV, VLADIMIR</au><au>SHAN, RUDONG</au><au>PETTIGREW, JEREMY D</au><au>MACKENZIE, LLOYD F</au><au>BOGUCKI, DAVID</au><au>RAYMOND, JEFFERY R</au><au>MACRURY, THOMAS B</au><au>HARWING, CURTIS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SHIP1 MODULATORS AND METHODS RELATED THERETO</title><date>2016-05-31</date><risdate>2016</risdate><abstract>Compounds of formula (I): [Formula should be inserted here]; where [Formula should be inserted here], n, R1, R4a, R4b, R5, R7 and R8 are defined herein, or pharmaceutically acceptable salts thereof, are described herein. The disclosed compounds have activity as SHIP1 modulators, and thus may be used to treat any of a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of formula (I) in combination with a pharmaceutically acceptable carrier or diluent are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof. Se describen compuestos de la fórmula (I): (Ver Fórmula) en donde: n, R1, R4a, R4b, R5, R7 y R8 son como se define en la presente, o sales farmacéuticamente aceptables de los mismos; los compuestos descritos tienen actividad como moduladores de SHIP1 y por lo tanto se pueden usar para tratar cualquiera de una variedad de enfermedades, trastornos o afecciones en las que la modulación de SHIP1 sería beneficiosa; también se describen composiciones que comprenden un compuesto de fórmula (I) en combinación con un vehículo o diluente farmacéuticamente aceptable, y métodos de modulación de SHIP1 mediante la administración de tales compuestos a un animal en necesidad de lo mismo.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2015008873A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title SHIP1 MODULATORS AND METHODS RELATED THERETO
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T12%3A02%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KHLEBNIKOV,%20VLADIMIR&rft.date=2016-05-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2015008873A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true